CD14 and COVID-19: Flow cytometric analysis of unstimulated whole blood samples revealed a significant increase in the percentage of IL-6+ CD14+ monocytes in patients with severe COVID-19 (n=4) compared with healthy volunteers (n=5; Fig. 5B).